Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Technological Advances
    3. Market Restraints
      1. High Initial Investment Costs
      2. High Development Costs and Resource Intensiveness
    4. Market Opportunities
      1. Increased Demand for Personalized Medicine and Precision Diagnostics
    5. Market Trends
      1. Surge of Cloud-Based Laboratory Information Management Systems (LIMS)
      2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
  5. MARKET SEGMENTATION
    1. By Process
      1. Continuous Flow
        1. By Workflow
          1. Sequential Processing
          2. Parallel Processing
        2. By Components
          1. Consumables
          2. Equipment
      2. Discrete Processing
        1. By Method
          1. Centrifugal Discrete Processing
          2. Random Access Discrete Processing
        2. By Components
          1. Consumables
          2. Equipment
        3. By Workflow
          1. Dependent Analysis
          2. Independent Analysis
    2. By Automation Type
      1. Total Automation Systems
        1. By Steps
          1. Pre-analysis
            1. Centrifugation
            2. Sample Preparation
            3. Sample Sorting
          2. Transport Mechanisms
          3. Liquid Handling
          4. Sample Storage
          5. Sample Analysis
      2. Modular Automation Systems
        1. By Steps
          1. Specimen Acquisition & Identification & Labelling
          2. Transport Mechanisms
          3. Sample Preparation
          4. Sample Loading & Aspiration
          5. Reagent Handling & Storage
          6. Sample Analysis & Measurements
    3. By End-Use
      1. Photometry & Fluorometry
      2. Immunoassay Analysis
      3. Electrolyte Analysis
      4. Other end-uses
      5. Clinical Chemistry Analysis
    4. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
    2. Alexion Pharmaceuticals, Inc.
    3. Amgen Inc.
    4. Bristol-Myers Squibb Company
    5. Biogen
    6. Celldex Therapeutics
    7. Eli Lilly and Company
    8. Eisai Co., Ltd.
    9. F. Hoffmann-La Roche Ltd.
    10. GSK plc.
    11. Kyowa Kirin Co., Ltd.
    12. Merck KGaA
    13. Novo Nordisk A/S
    14. Novartis AG
    15. Pfizer Inc.
    16. Takeda Pharmaceutical Company Limited

7. Vertex Pharmaceuticals Incorporated MARKET OPPORTUNITIES AND FUTURE TRENDS



Frequently Asked Questions

Q.1. What is the projected market value of the global laboratory automationmarket?

The global market of laboratory automation is projected to reach USD 9.5Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global laboratory automationmarket?

The global laboratory automation market has an estimated annual growth rate of 5.5% .

Q.3. What are the recent trends of laboratory automationmarket?

Surge of Cloud-Based Laboratory Information Management Systems (LIMS) and Integration of Artificial Intelligence (AI) and Machine Learning (ML)are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in laboratory automation?

The major companies profiled in this report include Alexion Pharmaceuticals, Inc., Amgen Inc., Bristol-Myers Squibb Company, Biogen, Celldex Therapeutics, Eli Lilly and Company, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., GSK plc., Kyowa Kirin Co., Ltd., Merck KGaA, Novo Nordisk A/S, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited., among others.

Q.5. Which region is estimated to held highest CAGR inlaboratory automationmarket?

North America is estimated to hold biggest share in the market for laboratory automation.

 

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.